Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors

Journal of Medicinal Chemistry

Volumn 39, Issue 4, 1996, Pages 850-859

  Brusniak, Mi Youn Kim ^a   Pearlman, Robert S ^a   Neve, Kim A ^b   Wilcox, Richard E ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIMETHYLAMINO 6,7 DIHYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 (4 HYDROXYPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADRENALIN; APOMORPHINE; BENZODIAZEPINE DERIVATIVE; BUTACLAMOL; DIHYDREXIDINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1A RECEPTOR; FENOLDOPAM; META TYRAMINE; NORADRENALIN; PROPYLNORAPOMORPHINE; RECEPTOR SUBTYPE; SEROTONIN; TYRAMINE; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG ABUSE; DRUG CONFORMATION; DRUG DESIGN; MOLECULAR CLONING; NONHUMAN; PARKINSON DISEASE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; SCHIZOPHRENIA;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COMPUTER GRAPHICS; DOPAMINE; DOPAMINE AGONISTS; GLIOMA; HUMANS; KINETICS; MODELS, MOLECULAR; RECEPTORS, DOPAMINE D1; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0030059848     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950447w     Document Type: Article

References (53)

1. Civelli, O.; Bunzow, J. R.; Grandy, D. K. Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol Toxicol 1993, 32, 281-307.
2. Civelli, O.; Bunzow, J. R.; Grandy, D. K.; Zhou, Q.-Y., Van Tol, H. H M. Molecular biology of the dopamine receptors Eur. J Pharmacol.-Mol. Pharmacol Sec. 1991, 207, 277-286
3. Gingrich, J. A.; Caron, M. G. Recent advances in the molecular biologv of dopamine receptors. Annu. Rev. Neurosci. 1993, 18, 299-321.
4. O'Dowd, B. F. Structures of dopamine receptors. J. Neurochem 1993, 60, 804-816.
5. Sibley, D. R.; Monsma, F. J., Jr Molecular biology of dopamine receptors. TIPS 1992, 13, 61-69.
6. Strange, P. G. Brain biochemistry and brain disorders: Oxford University Press: New York, 1993.
7. Waddington, J. D1:D2 Dopamine receptor interactions; Academic Press: New York, 1993.
8. Severson, J. A.; Wilcox, R. E. Agonist binding to striatal dopamine receptors in aging: the ternary complex of receptor and guanine nucleotide binding regulatory protein. Ann N.Y Acad. Sci. 1988, 524, 67-77.
9. Rogers, J.; Bloom, F. E. Neutotransmitter metabolism and function in the aging central nervous system. In Handbook of The Biology of Aging; Finch, C E., Schneider. E L., Eds , Van Nostrand Reinhold Co.: New York, 1985: pp 645-665.
10. (a) Lieberman, J.; Koreen, A. Neurochemistry and neuroendocrinology of schizophrenia, a selective review. Schiz. Bull 1993, 371-429
11. (b) Wilcox, R. E.; Gonzales, R. A. Introduction to neurotransmitters, receptors, signal transduction and second messengers. In Textbook of Psychopharmacology; Nemerorf, C. B., Schatzberg, A. F., Eds.: American Psychiatric Press: Washington, DC, 1995; Chapter 1, pp 3-31.
12. 1 dopamine receptor. Nature 1990. 347. 72-76.
13. Monsma, F. J., Jr., Mahan, L. C : McVittie, L. D.; Gerfen, C R., Sibley, D.R. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl Acad Sci. U.S.A. 1990, 87, 6723-6727.
14. 1 receptor encoded by an intronless gene on chromosome 5. Nature 1990, 347, 80-83.
15. Zhou, Q.-Y.; Grady, D./K.; Tharabi, L.; Kushner, J. A.; Van tol, H H. M.; Cone, R.; Pribnow, D.; Salon, J.; Bunzow, J. R.; Civelli, O. Cloning and expression of human and rat D1 dopamine receptors. Nature 1990, 347, 76-79.
16. Jarvie, K. R.; Tiberi, M.; Silvia, C.; Gingrich, J. A. Molecular cloning, stable expression and desensitization of the human dopamine D1B/D5 receptor. J. Recept. Res. 1993, 13, 573-590.
17. Tiberi, M ; Jarvie, K.; Silvia, C.; Falardeau, P.; Gingrich, J.; et al. Cloning, molecular characterization and chromosomal assignment of a gene encoding a novel D1 dopamine receptor subtype: differential expression pattern in rat brain compared to the D1A receptor. Proc Natl. Acad. Sci. U.S.A. 1991, 88, 8111.
18. Cox, B. A.; Henningsen, R. A.; Spanoyannis, A.; Neve, R L.; Neve, K. A. Contributions of conserved senne residues to the interactions of ligands with dopamine D2 receptors. J. Neurochem. 1992, 59, 627-635.
19. 2 receptor. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8111-8115.
20. Hibert, M. F.; Trump-Kallmeyer, S ; Bruinvels, A.; Hoflack, J. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 1991, 40, 8-15.
21. 2-like dopamine receptors. Biochem. J. 1992, 287, 277-282.
22. Teeter, M. M.; Froimowitz, M.; Stec, B.; DuRand, C. J Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists. J. Med. Chem. 1994, 37, 2874-2888
23. Moereels, H.; Leysen, J. E. Novel computational model for the interaction of dopamine with the D2 receptor. Recept. Channels 1993, 1, 89-97.
24. Hutchins, C. Three-dimensional models of the D1 and D2 dopamine receptors. Endocrine J. 1994, 2, 7-23.
25. Martin, Y. C. A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry J Med. Chem. 1981, 24, 229-237.
26. Martin, Y C. Computer-assisted rationale drug design Methods Enzymol. 1991, 203, 587-613.
27. Cramer, R. D., III; Depriest, S., Patterson, D.; Hecht, P. The developing practice of comparative molecular field analysis. In 3D QSAR in Drug Design - Theory, methods, and applications; ESCOM: Leiden, 1993; pp 443-485.
28. (b) Green, S. M.; Marshall, G R. 3D-QSAR: a current perspective. Trends Pharmacol. Sci. 1995, 16, 285-291.
29. Dunn, W. J.; Wold, S.; Edlund, V.; Helberg, S. Multivariate structure-activity relationships between data from a battery of biological tests and an ensemble of structure descriptors: the PLS method Quant. Struct.-Act Relat. 1984, 3, 131-137.
30. Langlois, M.; Bremont, B.; Rousselle, D.; Gaudy, F. Structural analysis by the comparative molecular field analysis method of the affinity of β-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 1993, 244, 77-87.
31. 1A receptor ligands by the method of comparative molecular field analysis. J. Compul. Chem 1993, 14, 237-245.
32. Martin, J. C.; Bures, M. G.; Danaher, E. A.; DeLazzer, J., Lico, I.; Pavlik, P. A. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
33. Mak, C.; Avalos, M.; Randall, P. K.; Whisennand, R.; Kwan, S.-W.; Abell, C. W.; Wilcox, R. E. Clonal cell lines stably expressing recombinant receptors, ideal systems for determining agonist affinity and efficacy. Neuropharmacology 1996, accepted for publication.
34. Goldman, M E.; Kebabian, J. W. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors. Mol. Pharmacol. 1984, 25, 18-23.
35. Machida, C., Searles, R ; Nipper, V.; Brown, J.; Kozell, L.; Neve, K. A. Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene. Mol. Pharmacol. 1992, 41, 652-659.
36. Kozell, L. B.; Machida, C. A.; Neve, R. L.; Neve, K. A. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. J. Biol Chem. 1994, 269, 30299-30306.
37. (a) Seeman, P. Brain dopamine receptors. Pharmacol. Rev. 1981, 32, 229-313.
38. (b) Starr, S.; Wiens, B.; Neve, K. A.; Pearlman, R. S.; Wilcox, R. E. Molecular basis for agonist selectivity at dopamine D1 and D2 receptors. Soc. Neurosci. Abstr. 1995, 21, (No. 252.11), 619.
39. 1 receptor affect ligand interactions and receptor activation. J. Biol. Chem. 1992, 267, 17780-17786.
40. SYBYL User's Manual Version 8.2; Tripos, Inc.: St. Louis, MO, 1995.
41. Pearlman, R. S. Rapid generation of high-quality approximate 3D molecular structures. Chem. Des. Auto. News 1987, 2, 1-9.
42. CONCORD User's Manual Version 3.0.1.; Tripos, Inc.: St. Louis, MO, 1993.
43. Marshall. G. R.; Barry, D. C.; Bosshard, H. E.; Dammkoehler, R. A., Dunn, D. A. The conformational parameter in drug design: the active analog approach. In Computer-Assisted. Drug Design; Olsen, E. C.; Christoffersen, R. E., Eds.; ACS Symposium Series 112: American Chemical Society: Washington, DC, 1979; pp 205-226.
44. Dewar, M.; Thiel, W. Ground states of molecules. 38. The MNDO method. Approximation and parameters. J. Am. Chem. Soc. 1977, 99, 4899-4917.
45. 1 receptor pharmacology. ISI Atlas Sci. 1988, 161-170.
46. Seeman, P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapme occupies D4. Neuropsychopharmacology 1992, 7, 261-284.
47. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 1994, 46, 157-203.
48. (a) Alkorta, I.; Villar, H. Considerations on the recognition of the D1 receptor by agonists. J. Comput.-Aided Mol. Des. 1993, 7, 659-670.
49. (b) Charifson, P.; Bowen, P.; Wyrick, S.; Hoffman, A.; Cory, M.; MePhail, A.; Mailman, R. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 receptor ligands. J. Med. Chem 1989, 32, 2050-2058.
50. (c) Additional details concerning the application of the various CoMFA applications used in this article may be found in: Brusniak, M.-Y. K. Development and application of software for CADD. Doctoral Dissertation, University of Texas at Austin, TX, 1996.
51. Wilcox, R. E.; Mak, C.; Avalos, M.; Randall, P.; Whisennand, R.; Kwan, S.-W.; Abell, C.; Neumeyer, J. Relative intrinsic efficacy and functional affinity constants of drugs in C6 glioma cells stably expressing the D1A dopamine receptor Soc. Neurosci. Abstr. 1993, 19, 75 (No, 38.5).
52. Bunzow, J.; VanTol, H.; Grandy, D.; Albert, P.; Salon, J.; Christie, M.; Machida, C.; Neve, K. A.; Civelli, O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988, 336, 783-787.
53. Sokoloff, P.; Giros, B.; Martres, M.-P.; Bouthenet, M -L.; Schwartz, J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347, 146-151.